Segura VY, Salas JE, Vindas PJ, Rojas UL

Language: Spanish
References: 18
Page: 6-13
PDF size: 527.84 Kb.

ABSTRACT

Bipolar disorder is a chronic disorder characterized by unusual intense mood shifts ranging from mania to depression. It affects an important percentage of the world population, and to women in their reproductive years. In pregnancy, it has deleterious effects on the fetus development, and it represents a big risk for the mother: self-injury, drugs abuse and suicide. Diagnosis is the most challenging step in management, because it determines the treatment plan, which is completly different than other psiquiatric disorder plan. Common drug classes used in pregnancy are lithium, atypical antipsychotics and lamotrigine. The purpose of this article is to inform about this mental illness, the risks of non-medication and the challenges involved in the treatment.

REFERENCES

1. Grande I Berk M Birmaher B & Vieta E. Bipolar disorder. The Lancet 2016; 387(10027): 1561– 1572.

2. Clark C Wisner K. Treatment of Peripartum Bipolar Disorder. Obstetrics and Gynecology Clinics of North America 2018; 45(3): 403–417.

3. Rowland T Marwaha S. Epidemiology and risk factors for bipolar disorder. Therapeutic Advances in Psychopharmacology 2018; 8(9): 251–269.

4. Yonkers K Wisner K Stowe Z et al. Management of Bipolar Disorder During Pregnancy and the Postpartum Period. American Journal of Psychiatry 2004; 161(4): 608–620.

5. Byatt N Cox L Moore T et al. Access to Pharmacotherapy Amongst Women with Bipolar Disorder during Pregnancy: a Preliminary Study. Psychiatric Quarterly 2017; 89(1): 183–190.

6. Thomson M Sharma V. Weighing the Risks the Management of Bipolar Disorder During Pregnancy. Current Psychiatry Reports 2018; 20(3).

7. Miller L Ghadiali N Larusso E. et al. Bipolar Disorder in Women. Health Care for Women International 2014; 36(4): 475–498.

8. Jones S Jones I. Pharmacological Management of Bipolar Disorder in Pregnancy. CNS Drugs 2017; 31(9): 737–745.

9. Hogan C Freeman M. Adverse Effects in the Pharmacologic Management of Bipolar Disorder During Pregnancy. Psychiatric Clinics of North America 2016; 39(3): 465–475.

10. Wald M Muzyk A Clark D. Bipolar Depression. Psychiatric Clinics of North America 2016; 39(1): 57–74.

11. Kennedy M. Medication management of bipolar disorder during the reproductive years. Mental Health Clinician 2017; 7(6): 255–261.

12. Kong L Zhou T Wang, B Gao Z Wang C. The risks associated with the use of lamotrigine during pregnancy. International Journal of Psychiatry in Clinical Practice 2017; 22(1): 2–5.

13. Özerdem A Akdeniz F. Pregnancy and postpartum in bipolar disorder. Neuropsychiatry 2014; 4(1): 95–107.

14. Campbell S Spigarelli M. Pharmacology and Pharmacogenomics of Neurological Medications Used in Pregnancy. Clinical Obstetrics and Gynecology 2013; 56(2): 305–316.

15. Muzik M Hamilton S. Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression. Maternal and Child Health Journal 2016; 20(11): 2268–2279.

16. Khan S Fersh M Ernst C Klipstein K Albertini E Lusskin S. Bipolar Disorder in Pregnancy and Postpartum: Principles of Management. Current Psychiatry Reports 2016; 18(2).

17. Dubovicky M Belovicova K Csatlosova K Bogi E. Risks of using SSRI / SNRI antidepressants during pregnancy and lactation. Interdisciplinary Toxicology 2017; 10(1): 30–34.

18. Jones I Chandra P Dazzan P Howard L. Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. The Lancet 2014; 384(9956): 1789–1799.